Journal of Clinical Virology
Volume 47, Issue 1 , Pages 13-17 , January 2010

Description of liver disease in a cohort of HIV/HBV coinfected patients

  • P. Sellier

      Affiliations

    • Service de Médecine Interne A, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, 2 rue Ambroise Paré, 75010 Paris, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 1 49 95 63 39; fax: +33 1 49 95 63 40.
    • ,
  • N. Schnepf

      Affiliations

    • Service de Bactériologie – Virologie, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, France
    • ,
  • I. Jarrin

      Affiliations

    • Service de Médecine Interne A, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, 2 rue Ambroise Paré, 75010 Paris, France
    • ,
  • M.-C. Mazeron

      Affiliations

    • Service de Bactériologie – Virologie, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, France
    • ,
  • G. Simoneau

      Affiliations

    • Service de Médecine Interne A, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, 2 rue Ambroise Paré, 75010 Paris, France
    • ,
  • M. Parrinello

      Affiliations

    • Centre d’Informations et de Soins de l’Immunodéficience Humaine, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, France
    • ,
  • J. Evans

      Affiliations

    • Immeuble SCOR, 1, avenue du General de Gaulle, Paris la Défense Cedex, France
    • ,
  • C. Lafuente-Lafuente

      Affiliations

    • Service de Médecine Interne A, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, 2 rue Ambroise Paré, 75010 Paris, France

Received 16 June 2009 ,Revised 5 October 2009 ,Accepted 7 October 2009.

References 

  1. Thio CL, Seaberg EC, Skolasky R, Phair J, Visscher B, Munoz A, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet. 2002;360:1921–1926
  2. Kellerman SE, Hanson DL, McNaghten AD, Fleming PL. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis. 2003;188:571–577
  3. Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS. 2005;19:593–601
  4. Sheng WH, Chen MY, Hsieh SM, Hsiao CF, Wang JT, Hung CC, et al. Impact of chronic hepatitis B virus (HBV) infection on outcomes of patients infected with HIV in an area where HBV infection is hyperendemic. Clin Infect Dis. 2004;38:1471–1477
  5. Gilson RJ, Hawkins AE, Beecham MR, Ross E, Waite J, Briggs M, et al. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS. 1997;11:597–606
  6. Colin JF, Cazals-Hatem D, Loriot MA, Martinot-Peignoux M, Pham BN, Auperin A, et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology. 1999;29:1306–1310
  7. Bonacini M, Louie S, Bzowej N, Wohl AR. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS. 2004;18:2039–2045
  8. McMahon BJ, Holck P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med. 2001;135:759–768
  9. Amin J, Law MG, Bartlett M, Kaldor JM, Dore GJ. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet. 2006;368:938–945
  10. Lacombe K, Massari V, Girard PM, Serfaty L, Gozlan J, Pialoux G, et al. Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV. AIDS. 2006;20:419–427
  11. Sheng WH, Hung CC, Kao JH, Chang SY, Chen MY, Hsieh SM, et al. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study. Clin Infect Dis. 2007;44:988–995
  12. ter Borg F, ten Kate FJ, Cuypers HT, Leentvaar-Kuijpers A, Oosting J, Wertheim-van Dillen PM, et al. Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigen. Lancet. 1998;351:1914–1918(Erratum in: Lancet 1999; 354:258)
  13. Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology. 2006;130:678–686
  14. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295:65–73
  15. Fonquernie L, Serfaty L, Charrois A, Wendum D, Lefebvre B, Girard PM, et al. Significance of hepatitis C virus coinfection with persistently normal alanine aminotransferase levels in HIV-1-infected patients. HIV Med. 2004;5:385–390
  16. Gonzalez SA, Liu R-C, Edlin BR, Jacobson IM, Talal AH. HIV/Hepatitis C virus-coinfected patients with normal alanine aminotransferase levels. J Acquir Immune Defic Syndr. 2006;41:582–589
  17. Sanchez-Conde M, Berenguer J, Miralles P, Alvarez F, Carlos Lopez J, Cosin J, et al. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase. Clin Infect Dis. 2006;43:640–644
  18. Maida I, Soriano V, Barreiro P, Rivas P, Labarga P, Nunez M. AIDS Res Hum Retroviruses. 2007;23:801–804
  19. Fang CT, Chen PJ, Chen MY, Hung CC, Chang SC, Chang AL, et al. Dynamics of plasma hepatitis B virus levels after highly active antiretroviral therapy in patients with HIV infection. J Hepatol. 2003;39:1028–1035
  20. Puoti M, Cozzi-Lepri A, Arici C, Moller NF, Lundgren JD, Ledergerber B, et al. Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysis. Antivir Ther. 2006;11:567–574
  21. Shamliyan TA, Macdonald R, Shaukat A, Taylor BC, Yuan JM, Johnson JR, et al. Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference. Ann Intern Med. 2009;150:111–124
  22. Soriano V, Puoti M, Bonacini M, Brook G, Cargnel A, Rockstroh J, et al. Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel. AIDS. 2005;19:221–240(Erratum in: AIDS. 2005;19:3 p following 640)
  23. Proceedings of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J Hepatol 2006;44(Supp1.):S77–94.
  24. Gaglio PJ, Sterling R, Daniels E, Tedaldi E Terry Beirn Community Programs for Clinical Research on AIDS Hepatitis Working Group. Hepatitis B virus and HIV coinfection: results of a survey on treatment practices and recommendations for therapy. Clin Infect Dis. 2007;45:618–623

PII: S1386-6532(09)00500-9

doi: 10.1016/j.jcv.2009.10.010

Journal of Clinical Virology
Volume 47, Issue 1 , Pages 13-17 , January 2010

Article Tools